AR021388A1 - Derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento - Google Patents

Derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento

Info

Publication number
AR021388A1
AR021388A1 ARP990105985A ARP990105985A AR021388A1 AR 021388 A1 AR021388 A1 AR 021388A1 AR P990105985 A ARP990105985 A AR P990105985A AR P990105985 A ARP990105985 A AR P990105985A AR 021388 A1 AR021388 A1 AR 021388A1
Authority
AR
Argentina
Prior art keywords
radicals
alkenyl
alkyl
alkynyl
erythromycin
Prior art date
Application number
ARP990105985A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR021388A1 publication Critical patent/AR021388A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente tiene por objeto los compuestos de formula (1) en la que: Y representa un átomo de hidrogeno o un átomo de fluor; n representa un numero enterocomprendido entre 1 y 8; Z representa un átomo de hidrogeno o el resto de un ácido carboxílico,eventualmente sustituido en el heterociclo con uno o variosradicales alquilo, alquenilo, alquinilo, O-alquilo, O-alquenilo, O-alquinilo, S-alquilo, S-alquenilo, S-alquinilo que contienen hasta 8 átomos de C, uno ovarios radicales OH, NH2, C=N, NO2,CF3 o uno o varios radicales arilo que contienen hasta 14 átomos de C o heteroarilo que contiene uno o varios átomos denitrogeno, oxígeno o azufre, pudiendo los radicales arilo o heteroarilo estar ellos mismo sustituidos así como sus sales de adicioncon ácidos. Los productosde formula (1) que presentan propiedades antibioticas.
ARP990105985A 1998-11-24 1999-11-24 Derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento AR021388A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (1)

Publication Number Publication Date
AR021388A1 true AR021388A1 (es) 2002-07-17

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105985A AR021388A1 (es) 1998-11-24 1999-11-24 Derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento

Country Status (24)

Country Link
US (2) US6440941B1 (es)
EP (1) EP1004592B1 (es)
JP (1) JP2000159790A (es)
KR (1) KR100587445B1 (es)
CN (1) CN1165546C (es)
AR (1) AR021388A1 (es)
AT (1) ATE245160T1 (es)
AU (1) AU772171B2 (es)
BR (1) BR9905735A (es)
CA (1) CA2290136C (es)
DE (1) DE69909577T2 (es)
DK (1) DK1004592T3 (es)
ES (1) ES2198867T3 (es)
FR (1) FR2786188B1 (es)
HU (1) HUP9904392A3 (es)
IL (1) IL133101A (es)
MX (1) MXPA99010813A (es)
NO (1) NO314729B1 (es)
PL (1) PL336736A1 (es)
PT (1) PT1004592E (es)
RU (1) RU2237672C2 (es)
TR (1) TR199902888A2 (es)
TW (1) TWI247747B (es)
ZA (1) ZA997176B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
IL144178A0 (en) * 1999-01-27 2002-05-23 Pfizer Prod Inc Ketolide antibiotics
TR200103395T2 (tr) 1999-05-24 2002-04-22 Pfizer Products Inc. 13-metil eritromisin türevleri.
ES2222966T3 (es) 2000-06-30 2005-02-16 Pfizer Products Inc. Macrolidos antibioticos.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
JP5698979B2 (ja) * 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
US8552162B2 (en) 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
DK2358379T3 (en) * 2008-10-24 2016-03-07 Cempra Pharmaceuticals Inc BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
US9173396B2 (en) 2010-10-22 2015-11-03 Bayer Intellectual Property Gmbh Heterocyclic compounds as pesticides
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
CA2905975A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EA199901016A1 (ru) * 1997-06-11 2000-06-26 Пфайзер Продактс Инк. 9-оксим-производные эритромицина
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Also Published As

Publication number Publication date
TR199902888A3 (tr) 2000-06-21
AU772171B2 (en) 2004-04-08
RU2237672C2 (ru) 2004-10-10
HUP9904392A3 (en) 2001-08-28
DE69909577T2 (de) 2004-06-03
ES2198867T3 (es) 2004-02-01
IL133101A (en) 2007-02-11
CA2290136C (fr) 2010-07-20
NO314729B1 (no) 2003-05-12
ZA997176B (en) 2000-11-20
NO995745L (no) 2000-05-25
PT1004592E (pt) 2003-12-31
HU9904392D0 (en) 2000-01-28
AU5952299A (en) 2000-05-25
EP1004592B1 (fr) 2003-07-16
JP2000159790A (ja) 2000-06-13
DE69909577D1 (de) 2003-08-21
NO995745D0 (no) 1999-11-23
KR20000057017A (ko) 2000-09-15
US6440941B1 (en) 2002-08-27
MXPA99010813A (es) 2005-09-08
US20030050254A1 (en) 2003-03-13
TR199902888A2 (xx) 2000-06-21
HUP9904392A2 (hu) 2000-05-28
TWI247747B (en) 2006-01-21
FR2786188B1 (fr) 2002-10-31
IL133101A0 (en) 2001-03-19
CN1263101A (zh) 2000-08-16
PL336736A1 (en) 2000-06-05
CN1165546C (zh) 2004-09-08
FR2786188A1 (fr) 2000-05-26
ATE245160T1 (de) 2003-08-15
US6664398B2 (en) 2003-12-16
KR100587445B1 (ko) 2006-06-08
BR9905735A (pt) 2000-08-08
CA2290136A1 (fr) 2000-05-24
DK1004592T3 (da) 2003-10-27
EP1004592A1 (fr) 2000-05-31

Similar Documents

Publication Publication Date Title
AR021388A1 (es) Derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento
CO6150179A2 (es) Derivados de n-(amino-heteroaril)-1h-hindol-2-carboxamidas su preparacion y su aplicacion en terapeutica
ECSP055746A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
AR061994A1 (es) Uso de derivados de imidazol activadores de ampk, su proceso de preparacion y composiciones farmaceuticas que los comprenden
PE20090111A1 (es) Derivados de bencimidazol
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
CR10643A (es) DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZOL[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
ES2189820T3 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
DK0385237T3 (da) 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
AR047974A1 (es) Derivados de alquilpiperazina y alquilhomopiperazina-carboxilatos, su preparacion y su aplicacion en terapeutica
NZ732351A (en) Compositions with improved urease-inhibiting effect comprising (thio) phosphoric acid triamide and further compounds such as amines and colorants
UA86013C2 (ru) Производные арилалкилкарбаматов, их получение и применение в лечении
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
CO6160310A2 (es) Nuevos derivados imidazolonas su preparacion como medicamentos composiciones farmaceuticas utilizacion como inhibidores de proteinas quinasas principalmente cdc7
HRP20040243B1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
HUP0500203A2 (hu) Acil-3-karboxi-fenil-karbamid-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR058208A1 (es) Derivados de indolizina,proceso de preparacion,composiciones farmaceuticas que los contienen y usos terapeuticos en alteraciones cardiovasculares.
BR9203643A (pt) Derivados de 3-cicloalquil-propen-2-amida e processo para sua preparacao,medicamentos e composicoes farmaceuticas
HUP0301040A2 (hu) Parazitaölő hatású 13 -szubsztituált milbemicinszármazékok, ezeket tartalmazó készítmények és alkalmazásuk
ES433982A1 (es) Procedimiento para la preparacion de agentes antihelminti- cos.
GB1080246A (en) 2-aryl-benzothiazole derivatives
AR046449A1 (es) Moleculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapeuticas
SE7706856L (sv) Nya karbamidsyraoximestrar till anvendning som fungicider och sett att framstella foreningarna
CU22837A3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparación y su aplicación como medicamentos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal